Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Life360, Inc. Director's Dealing 2025

Nov 23, 2025

30724_rns_2025-11-23_1d6c712b-d505-4121-adef-a9f269639118.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB APPROVAL

OMB Number: 3235-0287 Estimated average burden hours per response: 0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) See Instruction 10.

==> picture [677 x 287] intentionally omitted <==

----- Start of picture text -----

1. Name and Address of Reporting Person [] 2. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Burke Russell John Life360, Inc. [ LIF ] Director 10% Owner
(Last) (First) (Middle) 3. Date of Earliest Transaction (Month/Day/Year) X Officer (give title below) Other (specify below)
11/19/2025
Chief Financial Officer
C/O LIFE360, INC.
1900 SOUTH NORFOLK STREET, SUITE 310 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)
(Street) X Form filed by One Reporting Person
Form filed by More than One Reporting Person
SAN MATEO CA 94403
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction 2A. Deemed 3. 4. Securities Acquired (A) or Disposed Of (D) 5. Amount of Securities 6. 7. Nature of Indirect
Date Execution Date, Transaction (Instr. 3, 4 and 5) Beneficially Owned Ownership Beneficial Ownership
(Month/Day/Year) if any Code Following Reported Form: (Instr. 4)
(Month/Day/Year) (Instr. 8) Transaction(s) Direct (D)
(Instr. 3 and 4) or Indirect
Code V Amount (A) or Price (I) (Instr. 4)
(D)
Common stock 11/19/2025 M 6,500 A $ 3.58 98,232 (1) (2) D
Held by the Russell
Common Stock 72,553 (1) I John Burke
Revocable Trust
----- End of picture text -----*

==> picture [677 x 179] intentionally omitted <==

----- Start of picture text -----

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative 2. Conver 3. Transaction 3A. Deemed 4. 5. Number 6. Date Exercisable 7. Title and Amount of 8. Price 9. Number 10. Own 11. Nature
Security (Instr. 3) sion or Date Execution Date, Transaction of and Expiration Date Securities Underlying of Deriv of ership of Indirect
Exercise (Month/Day/Year) if any Code Derivative (Month/Day/Year) Derivative Security ative derivative Form: Beneficial
Price of (Month/Day/Year) (Instr. 8) Securities (Instr. 3 and 4) Security Securities Direct Ownershi
Derivative Acquired (Instr. 5) Beneficially (D) or p (Instr. 4)
Security (A) or Owned Indirect (
Disposed of Following I) (Instr.
(D) (Instr. 3, Reported 4)
4 and 5) Transaction
(s) (Instr. 4)
Amount
Date Ex or
ercisab Expiration Number
Code V (A) (D) le Date Title of Shares
Stock Option (right $ 3.58 11/19/2025 M 6,50 (3) 05/19/2030 Common stock 6,500 $ 0.00 434,014 D
to buy) 0
----- End of picture text -----

Explanation of Responses:

  1. The Reporting Person transferred 9,523 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

  2. Includes 91,732 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

  3. The stock option vested and became exercisable as to 50% of the total number of shares over a four-year period with a one-year cliff, such that 25% vested and became exercisable on May 11, 2021, and the remaining shares vested in 47 equal monthly installments thereafter; and as to 50% of the total number of shares over a three-year period with a one-year cliff, such that 25% vested and became exercisable on May 11, 2021, and the remaining shares vested in 35 equal monthly installments thereafter, subject to the continuing employment of the Reporting Person on each vesting date. The stock option is now fully vested and exercisable.

Remarks:

The vesting terms for the stock option reported herein were inadvertently misreported on the Reporting Person's initial Form 3 filed on June 27, 2022, and subsequent Forms 4 reporting transactions in the stock option, and have been corrected as of this Form 4.

/s/ Allison Chang, Attorney-in-Fact 11/21/2025 ** Signature of Reporting Person Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

  • If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.